Clinical and Radiographic Evaluation of Injectable Composite Versus Packable Composite in Restoring of Primary Molars

April 11, 2026 updated by: Eslam samy abdel monaem kalboush

Clinical and Radiographic Assessment of Injectable Composite Versus Packable Composite in the Restoration of Cavitated Primary Molars a Randomized Clinical Trial

This randomized clinical trial aims to compare the clinical and radiographic performance of injectable composite versus packable composite in restoring cavitated primary molars in children aged 4 to 8 years.

Study Purpose

To determine whether injectable composite performs as well as packable composite in Class II restorations in primary molars clinically and radiographically.

Study Overview

Status

Not yet recruiting

Detailed Description

This randomized clinical trial aims to compare the clinical and radiographic performance of injectable composite versus packable composite in restoring cavitated primary molars in children aged 4-8 years.

Study Purpose

To determine whether injectable composite performs as well packable composite in Class II restorations in primary molars.

Study Design

Type: Randomized clinical trial

Sample: 64 primary molars (32 per group)

Allocation: 1:1 using concealed envelopes

Group I (Experimental group): Injectable composite (Beautifil Flow Plus X F00, Shofu, Japan) Group II (Control group): Packable composite (Beautifil II LS, Shofu, Japan)

Follow-up: Clinical at 3, 6, 12 months

Radiographic at 0, 6, 12 months

Location: Pediatric Dentistry Clinic, Cairo University

Outcome Measures

Primary Outcome Clinical Performance (FDI Criteria):

Functional: marginal adaptation, fracture, proximal contact, occlusion, wear

Biological: caries at margins, hard tissue defects, sensitivity, pulp status

Esthetic: texture, staining, color match

Secondary Outcome Radiographic Performance:

Presence/absence of voids

Marginal integrity on bitewing radiographs

Rationale

Injectable composites may offer:

Better cavity adaptation

Easier handling

Shorter chair time (important in pediatric dentistry)

Packable composites offer:

Higher strength and wear resistance

The study investigates whether injectables can match or outperform packables clinically.

Hypothesis

Null hypothesis: There is no difference between injectable and packable composites in clinical and radiographic success.

Intervention The principal investigator ES will carry out all treatment procedures, and the patients will be randomly assigned to any of them.

For both groups:

  1. Informed consent from participating children parents.
  2. Baseline records photographs, percussion test, periapical radiograph and personal data collection (Appendix 1: Diagnostic chart).
  3. Diagnostic chart with personal, medical and dental history will be filled (Appendix 1:

    Diagnostic chart).

  4. Allocation (concealed by withdrawing a sealed opaque envelope containing Four-folded numbered papers containing the type of restorative material that will be used then writing the patient name and I.D. on it and will be opened after performing the cavity).
  5. Clinical examination will be performed to assess the clinical inclusion criteria.
  6. Preoperative and Postoperative photographs will be taken.
  7. The radiographic examination will be performed by taking a periapical x-ray using (bitewing technique) to assess the inclusion criteria. The preoperative radiograph will serve as a reference for the follow-up radiographs.
  8. Administration of local anesthesia at the side of the affected tooth.
  9. Application of rubber dam for isolation, then caries removal procedure will be performed using a sterile round-end bur in a high-speed handpiece
  10. After cavity preparation, conditioning of the tooth will be done using 35% phosphoric acid for 30 seconds for enamel and 15 seconds for dentin. Then, after rinsing the acid etch with water for 10 seconds, bond will be applied to the tooth using a bond brush and then cured for 5 seconds.
  11. The restorative material will be placed in the cavity and will be cured for 20 seconds per increment for the intervention group and for 20 seconds for the control group (17).
  12. The last step is to finish and polish the restoration material with abrasive rubber tips using the KENDA C.G.I polishing system (Coltene, Switzerland) (
  13. Clinical assessment will be done after each visit using FDI criteria to assess the clinical performance of each restoration in the three domains (biological, functional and aesthetics) and radiographic assessment will be done for 0, 6, and 12 months using periapical bitewing x-ray.

Sample size calculation:

Data will be analyzed using Medcalc software, version 22 for Windows (MedCalc Software Ltd, Ostend, Belgium).

Categorical data will be described as frequency and percentage. Intergroup Comparisons between categorical variables will be performed using the chi-square test, while intragroup comparisons within each intervention will be performed using Cochran's Q test followed by pairwise multiple comparisons.

A p-value less than or equal to 0.05 will be considered statistically significant, and all tests will be two-tailed. Statistical power of the study will be set at 80% with a 95% confidence level.

The sample size was calculated based on a previous study by Inthihas et al in 2019, in which the success rate of proximal giomer restorations in primary molars was 94.1% after 12 months (17).

By implementing a two tailed Z test for the difference between two independent proportions with an alpha level of 5% and a power of 80%.

The minimum sample size needed was 28 per group in order to detect a difference of 30%.

Sample size was increased by 15% to compensate for possible dropouts to reach 32 teeth per group. Sample size was performed using G*Power version 3.1.9.2 for windows.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt, 11553
        • Faculty of Dentistry,Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients:

    • Children aged 4-8 years.
    • Medically free.

Teeth:

  • Restorable Class II cavities.
  • Asymptomatic tooth.

Pre-operative radiographic examination:

  • Absence of periapical or inter-radicular radiolucency.
  • Absence of widening of periodontal ligaments space.
  • Absence of internal or external root resorption.

Exclusion Criteria:

  • Patients:

    • Uncooperative children.
    • Unable to attend follow-up visits.
    • Parents refuse to sign the informed consent.
    • Children participating in any other clinical trial involving fluoride therapy or other interventions that could directly influence caries development during the study period.

Teeth:

  • Teeth which were previously restored.
  • Mobility.

Pre-operative radiographic examination:

  • Caries extending deep sub-gingivally.
  • The tooth is about to exfoliate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: injectable composite
it is a type of zero flow injectable composite used to restore teeth and molars
type of zero flow injectable composite
Other: Packable composite
composite used to restore molars
packable composite used to restore teeth and molars

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Assessment of Injectable Composite Versus Packable Composite in The Restoration of Cavitated Primary Molars
Time Frame: Time: T0 = baseline assessment and procedure will be done. T1 =3 months follow up. T2 = 6 months follow up. T3 = One-year follow-up.

Clinical evaluation will be done according to Fédération Dentaire Internationale FDI criteria

Scores:

Clinically excellent = 1 Clinically good = 2 Clinically sufficient = 3 Clinically unsatisfactory = 4 Clinically poor = 5

Time: T0 = baseline assessment and procedure will be done. T1 =3 months follow up. T2 = 6 months follow up. T3 = One-year follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic Assessment of Injectable Composite Versus Packable Composite in The Restoration of Cavitated Primary Molars.
Time Frame: t = 0 months t2 = 6 months t3 = 12 months
radiographic assessment will be done by using bitewing x-ray
t = 0 months t2 = 6 months t3 = 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eslam Kalboush, Mcs, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

November 16, 2025

First Submitted That Met QC Criteria

November 16, 2025

First Posted (Actual)

November 20, 2025

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 11, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 191131345021234567891911313450

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries in Children

Clinical Trials on injectable composite

Subscribe